A major advance in cancer investigation is emerging with the use of mini-antibodies to reactivate damaged p53. This essential malignant inhibitor protein is frequently lost in several types of cancer, causing https://cruxbookmarks.com/story22040020/nanobodies-restore-the-p53-protein-a-promising-approach-for-tumor-treatment